Menopause Supplement Industry To Grow To $22.7 Billion By 2028 As Women Seek Out Alternative Treatments

13 million women in the UK are currently perimenopausal or menopausal which represents one third of the female population. An estimated 63% of these women say that their menopause symptoms have negatively impacted their work with many incredibly keen to find treatment, support and guidance.

The global menopause supplement industry is expected to reach $22.7 billion by 2028 according to figures from a report by Grand View Research Inc. as women seek out alternative therapy to Hormone Replacement Therapy (HRT) and antidepressants.

According to Dr Paul Clayton, professor, leading clinical pharmacologist and pharmaco-nutritionist at health brand LYMA: “The industry consists of companies selling unvalidated, poorly formulated, over-hyped products which offer few, if any benefits.” This is why LYMA, a supplement specialist brand, has launched a peri-menopause and menopause advice service, offering every woman a free ‘Supplement MOT’ from their team of experts throughout October which is Menopause Awareness Month.

LYMA has explained that the aim of the service, which will be managed by a team of experts including doctors specifically trained on the use and effectiveness of supplements, is to help women decode and demystify the world of menopause supplements.

LYMA Founder Lucy Goff explains:“Our Concierge service is inundated with requests and we’ve become an authority for customers who want to know what works and what doesn’t in the supplement industry. We found that around 70% of the calls we were receiving were from menopausal and peri-menopausal and so we’ve launched this dedicated service to help them to navigate through this time in their lives.”

The supplement company often referred to as ‘the supermodel supplement’ claims that it has seen exponential growth since it was founded four years ago and now ships its products to over seventy countries globally.

It was Goff’s perceived lack of efficacy in the supplement industry that was a central reason in her journey to found LYMA: “The idea came from my own health battle and my own desperation to feel well again, after having septicaemia and taking a cocktail of supplements that it transpired simply didn’t work. People turn to the supplement industry often in a desperate attempt to feel better or address a concern and this is true for perimenopausal and menopausal women who are sadly all too often let down by an unregulated industry.”

She adds: “The industry feeds off consumer neuroses, rather than anything evidence based. It manipulates women into thinking they need to take a load of ingredients that you can easily (and are best placed) to consume through a healthy balanced diet. This is why most supplement brands include a fairly generic list of vitamins, minerals and phytonutrients, when in fact it’s far more beneficial to eat nutritious, unprocessed foods, rather than pop a multivitamin.”

LYMA stands by its credentials to create an alternative solution, though at £149 per month for the required dosage, this is certainly the “Rolls Royce” of the supplement world. LYMA states that its product has undergone significant research and development with outcomes have been published in over 200 peer-reviewed medical journals. The business highlights the product success starts with its ingredients.

“They are considerably more expensive to use than generic or organic ingredients, which is why they’re rarely used in the supplement industry, and when they are, they are often severely underdosed” clarifies Goff.

“The launch of the LYMA Supplement MOT service is to help women to understand what they are taking and if their Supplement is optimally formulated to deliver the benefits it should. You wouldn’t take a pharmaceutical drug at a lesser dose and expect it to work, so you shouldn’t expect anything less from a supplement either.”

Campaigning for better education, medication and support for menopause is ongoing, but when the largest and most powerful generation hits that life stage, is now the time the nation will finally see change? A recent report by Deloitte estimated the ‘Peri-Millennial’ – the perimenopausal millennial – will make up over 37% of the global workforce by 2025 and yet symptoms of perimenopause and menopause are still either mistreated or alternative, holistic solutions are unrecognised.

A 2021 UK parliamentary inquiry into menopause and the workplace highlighted that a lack of support can mean women are often leaving employment at the peak of their experience with an obvious knock on effect to senior leadership diversity and gender pay parity.

The ‘Supplement MOT’ is available throughout October at LYMA.